Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine

Keyphrases

• Muscarinic Receptors 100%
• Receptor-mediated 100%
• Cyclic GMP 100%
• Polyphosphoinositide Hydrolysis 100%
• Pirenzepine 100%
• Non-competitive Antagonism 100%
• Non-competitive 37%
• Incubation 25%
• Antagonism 12%
• High Concentration 12%
• Non-equilibrium 12%
• Atropine 12%
• Exposure Time 12%
• Concentration-dependent 12%
• Cell Clones 12%
• Ligand Binding 12%
• N1E-115 12%
• Competitive Antagonism 12%
• Equilibrium State 12%
• Specific Conditions 12%
• Mouse Neuroblastoma Cells 12%
• Competitive Antagonist 12%
• Muscarinic Agonists 12%
• Approaches to Study 12%

Neuroscience

• Cyclic Guanosine Monophosphate 100%
• Pirenzepine 100%
• Muscarinic Acetylcholine Receptor 100%
• Phosphatidylinositide 100%
• Neuroblastoma 12%
• Muscarinic Agonist 12%
• Ligand Binding 12%
• Competitive Inhibition 12%
• Receptor 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Muscarinic Receptor 100%
• Phosphatidylinositide 100%
• Cyclic GMP 100%
• Pirenzepine 100%
• Receptor 12%
• Neuroblastoma 12%
• Muscarinic Agent 12%